Kyobo 11 Special Purpose Acquisition Resultados de beneficios anteriores
Pasado controles de criterios 4/6
Kyobo 11 Special Purpose Acquisition has been growing earnings at an average annual rate of 81.3%, while the Chemicals industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 39.5% per year. Kyobo 11 Special Purpose Acquisition's return on equity is 23.7%, and it has net margins of 16.1%.
Información clave
81.3%
Tasa de crecimiento de los beneficios
65.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 13.9% |
| Tasa de crecimiento de los ingresos | 39.5% |
| Rentabilidad financiera | 23.7% |
| Margen neto | 16.1% |
| Última actualización de beneficios | 30 Jun 2023 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Desglose de ingresos y gastos
Cómo gana y gasta dinero Kyobo 11 Special Purpose Acquisition. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 23 | 21,088 | 3,390 | 3,797 | 1,076 |
| 31 Mar 23 | 18,560 | 2,756 | 3,744 | 1,005 |
| 31 Dec 22 | 16,032 | 2,121 | 3,691 | 934 |
| 31 Dec 21 | 14,219 | 1,623 | 3,012 | 778 |
| 31 Dec 20 | 13,858 | 1,475 | 2,599 | 761 |
Ingresos de calidad: A397880 has high quality earnings.
Margen de beneficios creciente: A397880's current net profit margins (16.1%) are higher than last year (12.4%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Insufficient data to determine if A397880's year-on-year earnings growth rate was positive over the past 5 years.
Acelerando crecimiento: Insufficient data to compare A397880's past year earnings growth to its 5-year average.
Beneficios vs. Industria: A397880 earnings growth over the past year (81.3%) exceeded the Chemicals industry -6.3%.
Rentabilidad financiera
Alta ROE: A397880's Return on Equity (23.7%) is considered high.